Literature DB >> 20453025

Adipokine concentrations in nonobese women: a study of reproductive aging, body mass index, and menstrual cycle effects.

Patricia A Rouen1, Jane L Lukacs, Nancy E Reame.   

Abstract

OBJECTIVE: To explore the influence of reproductive aging, body mass index (BMI), and the menstrual cycle on adiponectin (AD) and leptin concentrations.
DESIGN: Cross-sectional comparison in age- and BMI-matched nonobese volunteers with regular cycles (CO, n = 19) or in early postmenopause (EPM, n = 19), aged 40-52 years, and a young cycling group (CY, n = 21), aged 20-30 years. MEASURES: Sex steroids, fasting AD, leptin, insulin, glucose, AD/leptin (A/L) ratio, and insulin resistance (IR) by homeostasis model assessment (HOMA-IR). In ovulatory women, AD, estradiol (E(2)), and progesterone were assessed weekly across the same menstrual cycle.
RESULTS: Insulin, glucose, HOMA-IR, A/L ratio, and leptin values were similar across the three study groups. AD differed, with the highest concentrations in the EPM group (CY: 13.0 +/- 0.9 microg/ml vs. CO: 14.0 +/- 1.1 microg/ml vs. EPM: 17.7 +/- 1.5 microg/ml; p = .05). Values among cycling women were similar. When the cycling groups were combined into a premenopausal (PRE) group and compared to EPM women by BMI (> or <or=25 kg/m(2)), leptin concentrations were higher and A/L ratios lower in PRE and EPM overweight (OW) subgroups versus normal-weight (NW) subgroups. AD was lower in OW, cycling women and higher in the NW EPM subgroup compared to NW PRE women. In cycling women, AD did not vary across the menstrual cycle.
CONCLUSION: Nonobese, midlife women experience minimal adverse effects from reproductive aging on insulin sensitivity and adipokine secretion. The menstrual cycle is not a key mediator of AD. Early menopause has differential, BMI-dependent effects on adipokine secretion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20453025      PMCID: PMC3128347          DOI: 10.1177/1099800410365368

Source DB:  PubMed          Journal:  Biol Res Nurs        ISSN: 1099-8004            Impact factor:   2.522


  39 in total

1.  Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution.

Authors:  Steen B Pedersen; Kurt Kristensen; Pernille A Hermann; John A Katzenellenbogen; Bjørn Richelsen
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

2.  Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

Authors:  M Cnop; P J Havel; K M Utzschneider; D B Carr; M K Sinha; E J Boyko; B M Retzlaff; R H Knopp; J D Brunzell; S E Kahn
Journal:  Diabetologia       Date:  2003-04-10       Impact factor: 10.122

3.  The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Yong-Woo Park; Shankuan Zhu; Latha Palaniappan; Stanley Heshka; Mercedes R Carnethon; Steven B Heymsfield
Journal:  Arch Intern Med       Date:  2003-02-24

4.  Leptin and adiponectin blood levels in women with premature ovarian failure and age- and weight-matched women with normal menstrual cycles.

Authors:  Cristina Laguna Benetti-Pinto; Natália Castro; Oswaldo da Rocha Grassiotto; Heraldo Mendes Garmes
Journal:  Menopause       Date:  2010 Jan-Feb       Impact factor: 2.953

5.  Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies.

Authors:  Alina Gavrila; Jean L Chan; Nikos Yiannakouris; Meropi Kontogianni; Lisa C Miller; Christine Orlova; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

6.  Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women.

Authors:  Meropi D Kontogianni; Urania G Dafni; John G Routsias; Fotini N Skopouli
Journal:  J Bone Miner Res       Date:  2004-01-05       Impact factor: 6.741

Review 7.  The emergence of the metabolic syndrome with menopause.

Authors:  Molly C Carr
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

Review 8.  The adipocyte as an endocrine cell.

Authors:  J L Miner
Journal:  J Anim Sci       Date:  2004-03       Impact factor: 3.159

9.  Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein.

Authors:  Hitoshi Nishizawa; Iichiro Shimomura; Ken Kishida; Norikazu Maeda; Hiroshi Kuriyama; Hiroyuki Nagaretani; Morihiro Matsuda; Hidehiko Kondo; Naoki Furuyama; Shinji Kihara; Tadashi Nakamura; Yoshihiro Tochino; Tohru Funahashi; Yuji Matsuzawa
Journal:  Diabetes       Date:  2002-09       Impact factor: 9.461

Review 10.  Leptin: a review of its peripheral actions and interactions.

Authors:  S Margetic; C Gazzola; G G Pegg; R A Hill
Journal:  Int J Obes Relat Metab Disord       Date:  2002-11
View more
  1 in total

1.  The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS.

Authors:  Anand Vaidya; Jonathan S Williams; John P Forman
Journal:  Obesity (Silver Spring)       Date:  2011-07-14       Impact factor: 5.002

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.